These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11243961)

  • 41. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
    Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
    J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
    Heaton AH; Bryant J; Berman BN; Trotter JP
    Med Interface; 1996 Jan; 9(1):101-7. PubMed ID: 10153789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors influencing the length of hospital stay of patients with heart failure.
    Wright SP; Verouhis D; Gamble G; Swedberg K; Sharpe N; Doughty RN
    Eur J Heart Fail; 2003 Mar; 5(2):201-9. PubMed ID: 12644013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.
    Salvador DR; Rey NR; Ramos GC; Punzalan FE
    Cochrane Database Syst Rev; 2004; (1):CD003178. PubMed ID: 14974008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation.
    van der Vorst MM; Wildschut E; Houmes RJ; Gischler SJ; Kist-van Holthe JE; Burggraaf J; van der Heijden AJ; Tibboel D
    Crit Care; 2006; 10(6):R168. PubMed ID: 17140428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
    Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
    Spannheimer A; Goertz A; Dreckmann-Behrendt B
    Int J Clin Pract; 1998 Oct; 52(7):467-71. PubMed ID: 10622087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
    Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
    J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
    Imiela T; Budaj A
    Clin Drug Investig; 2017 Dec; 37(12):1175-1181. PubMed ID: 28965280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
    Afari ME; Aoun J; Khare S; Tsao L
    Heart Fail Rev; 2019 May; 24(3):309-313. PubMed ID: 30617666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
    Cotter G; Metzkor E; Kaluski E; Faigenberg Z; Miller R; Simovitz A; Shaham O; Marghitay D; Koren M; Blatt A; Moshkovitz Y; Zaidenstein R; Golik A
    Lancet; 1998 Feb; 351(9100):389-93. PubMed ID: 9482291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intravenous furosemide for acute heart failure : continuous infusion or intermittent bolus ?].
    Dias J; Carballo S; Meyer P; Darbellay Farhoumand P; Agoritsas T
    Rev Med Suisse; 2022 Oct; 18(801):2004-2011. PubMed ID: 36314090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
    Okuhara Y; Hirotani S; Naito Y; Nakabo A; Iwasaku T; Eguchi A; Morisawa D; Ando T; Sawada H; Manabe E; Masuyama T
    J Card Fail; 2014 May; 20(5):295-301. PubMed ID: 24462960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.